Sandbox g23

Jump to navigation Jump to search

Encephalitis

  • Empiric antimicrobial therapy[1]
  • Preferred regimen: Acyclovir 10 mg/kg IV q8h for 14–21 days
Note (1): Acyclovir should be initiated in all patients with sus- pected encephalitis, pending results of diagnostic studies.
Note (2): Other empirical antimicrobial agents should be initiated on the basis of specific epidemiologic or clinical clues.
  • Specific epidemiologic considerations[2]
  • Agammaglobulinemia — Enteroviruses, Mycoplasma pneumoniae
  • Age
  • Neonates — Herpes simplex virus type 2, cytomegalovirus, rubella virus, Listeria monocytogenes, Treponema pallidum, Toxoplasma gondii
  • Infants and children — Eastern equine encephalitis virus, Japanese encephalitis virus, Murray Valley encephalitis virus, influenza virus, La Crosse virus
  • Elderly persons — Eastern equine encephalitis virus, St. Louis encephalitis virus, West Nile virus, sporadic CJD, L. monocytogenes
  • Animal contact
  • Bats — Rabies virus, Nipah virus
  • Birds — West Nile virus, Eastern equine encephalitis virus, Western equine encephalitis virus, Venezuelan equine encephalitis virus, St. Louis encephalitis virus, Murray Valley encephalitis virus, Japanese encephalitis virus, Cryptococcus neoformans (bird droppings)
  • Cats — Rabies virus, Coxiella burnetii, Bartonella henselae, T. gondii
  • Dogs — Rabies virus
  • Horses — Eastern equine encephalitis virus, Western equine encephalitis virus, Venezuelan equine encephalitis virus, Hendra virus
  • Old World primates — B virus
  • Raccoons — Rabies virus, Baylisascaris procyonis
  • Rodents — Eastern equine encephalitis virus (South America), Venezuelan equine encephalitis virus, tickborne encephalitis virus, Powassan virus (woodchucks), La Crosse virus (chipmunks and squirrels), Bartonella quintana
  • Sheep and goats — C. burnetii
  • Skunks — Rabies virus
  • Swine — Japanese encephalitis virus, Nipah virus
  • White-tailed deer — Borrelia burgdorferi
  • Immunocompromised persons — Varicella zoster virus, cytomegalovirus, human herpesvirus 6, West Nile virus, HIV, JC virus, L. monocytogenes, Mycobacterium tuberculosis, C. neoformans, Coccidioides species, Histoplasma capsula- tum, T. gondii
  • Ingestion
  • Raw or partially cooked meat — T. gondii
  • Raw meat, fish, or reptiles — Gnanthostoma species
  • Unpasteurized milk — Tickborne encephalitis virus, L. monocytogenes, C. burnetii
  • Insect contact
  • Mosquitoes — Eastern equine encephalitis virus, Western equine encephalitis virus, Venezuelan equine encephalitis virus, St. Louis encephalitis virus, Murray Valley encephalitis virus, Japanese encephalitis virus, West Nile virus, La Crosse virus, Plasmodium falciparum
  • Sandflies — Bartonella bacilliformis
  • Ticks — Tickborne encephalitis virus, Powassan virus, Rickettsia rickettsii, Ehr- lichia chaffeensis, Anaplasma phagocytophilum, C. burnetii (rare), B. burgdorferi
  • Tsetse flies — Trypanosoma brucei gambiense, Trypanosoma brucei rhodesiense
  • Occupation
  • Exposure to animals — Rabies virus, C. burnetii, Bartonella species
  • Exposure to horses — Hendra virus
  • Exposure to Old World primates — B virus
  • Laboratory workers — West Nile virus, HIV, C. burnetii, Coccidioides species
  • Physicians and health care workers — Varicella zoster virus, HIV, influenza virus, measles virus, M. tuberculosis
  • Veterinarians — Rabies virus, Bartonella species, C. burnetii
  • Person-to-person transmission — Herpes simplex virus (neonatal), varicella zoster virus, Venezuelan equine encephalitis virus (rare), poliovirus, nonpolio enteroviruses, measles virus, Nipah virus, mumps virus, rubella virus, Epstein-Barr virus, human herpesvirus 6, B virus, West Nile virus (transfusion, transplantation, breast feeding), HIV, rabies virus (transplantation), influenza virus, M. pneumoniae, M. tuberculosis, T. pallidum
  • Recent vaccination — Acute disseminated encephalomyelitis
  • Recreational activities
  • Camping/hunting — Agents transmitted by mosquitoes and ticks
  • Sexual contact — HIV, T. pallidum
  • Spelunking — Rabies virus, H. capsulatum
  • Swimming — Enteroviruses, Naegleria fowleri
  • Season
  • Late summer/early fall — All agents transmitted by mosquitoes and ticks (see above), enteroviruses
  • Winter — Influenza virus
  • Transfusion and transplantation — Cytomegalovirus, Epstein-Barr virus, West Nile virus, HIV, tickborne encephalitis virus, rabies virus, iatrogenic CJD, T. pallidum, A. phagocytophilum, R. rickettsii, C. neoformans, Coccidioides species, H. capsulatum, T. gondii
  • Travel
  • Africa — Rabies virus, West Nile virus, P. falciparum, T. brucei gambiense, T. brucei rhodesiense
  • Australia — Murray Valley encephalitis virus, Japanese encephalitis virus, Hendra virus
  • Central America — Rabies virus, Eastern equine encephalitis virus, Western equine en- cephalitis virus, Venezuelan equine encephalitis virus, St. Louis en- cephalitis virus, R. rickettsii, P. falciparum, Taenia solium
  • Europe — West Nile virus, tickborne encephalitis virus, A. phagocytophilum, B. burgdorferi
  • India, Nepal — Rabies virus, Japanese encephalitis virus, P. falciparum
  • Middle East — West Nile virus, P. falciparum
  • Russia — Tickborne encephalitis virus
  • South America — Rabies virus, Eastern equine encephalitis virus, Western equine en- cephalitis virus, Venezuelan equine encephalitis virus, St. Louis encephalitis virus, R. rickettsii, B. bacilliformis (Andes mountains), P. falciparum, T. solium
  • Southeast Asia, China, Pacific Rim — Japanese encephalitis virus, tickborne encephalitis virus, Nipah virus, P. falciparum, Gnanthostoma species, T. solium
  • Unvaccinated status — Varicella zoster virus, Japanese encephalitis virus, poliovirus, measles virus, mumps virus, rubella virus
  • Specific clinical considerations[3]


  • Pathogen-directed antimicrobial therapy[4]
  • Viruses
  • Preferred regimen: supportive
prophylactic antiviral therapy after bite or scratch
established disease
  • Preferred regimen: supportive
  • Preferred regimen: supportive
  • HSV-1 and HSV-2
  • Preferred regimen: Acyclovir 10 mg/kg IV q8h for 14–21 days
  • Preferred regimen (neonates): Acyclovir 20 mg/kg IV q8h for 21 days


  • Preferred regimen: supportive
  • Preferred regimen: Reversal or control of immunosuppression AND HAART in patients with AIDS
  • Preferred regimen: supportive
life-threatening disease
SSPE
  • Preferred regimen: supportive
  • Preferred regimen: supportive
  • Preferred regimen: supportive AND Intraventricular γ-globulin (for chronic and/or severe disease)
  • Preferred regimen: supportive
  • Preferred regimen: supportive
postxposure prophylaxis
  • Preferred regimen: rabies immunoglobulin AND vaccine
after onset of disease
  • Preferred regimen: supportive
  • Preferred regimen: supportive
  • St. Louis encephalitis virus
  • Preferred regimen: supportive
  • Alternative regimen: IFN-a-2b
  • Tickborne encephalitis virus
  • Preferred regimen: supportive
  • Preferred regimen: supportive
  • Preferred regimen: supportive
  • Preferred regimen: supportive
  • Bacteria
  • Ehrlichia chaffeensis (human monocytotrophic ehrlichiosis)
with meningitis
without meningitis
  • Fungi
  • Preferred regimen: Amphotericin B deoxycholate AND flucytosine for 2 weeks, followed by fluconazole for 8 weeks ORv Lipid formulation of amphotericin B AND flucytosine for 2 weeks, followed by fluconazole for 8 weeks OR Amphotericin B AND flucytosine for 6–10 weeks
  • Preferred regimen: Liposomal amphotericin B for 4–6 weeks, followed by itraconazole for at least 1 year and until resolution of CSF abnormalities
  • Protozoa
  • Preferred regimen: Quinine OR quinidine OR artesunate OR artemether
  • Alternative regimen: Atovaquone OR proguanil OR Exchange transfusion (less than 10% parasitemia or cere- bral malaria)
  • Helminths
  • Prion
  • Preferred regimen: supportive
  1. Tunkel, Allan R.; Glaser, Carol A.; Bloch, Karen C.; Sejvar, James J.; Marra, Christina M.; Roos, Karen L.; Hartman, Barry J.; Kaplan, Sheldon L.; Scheld, W. Michael; Whitley, Richard J.; Infectious Diseases Society of America (2008-08-01). "The management of encephalitis: clinical practice guidelines by the Infectious Diseases Society of America". Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America. 47 (3): 303–327. doi:10.1086/589747. ISSN 1537-6591. PMID 18582201.
  2. Tunkel, Allan R.; Glaser, Carol A.; Bloch, Karen C.; Sejvar, James J.; Marra, Christina M.; Roos, Karen L.; Hartman, Barry J.; Kaplan, Sheldon L.; Scheld, W. Michael; Whitley, Richard J.; Infectious Diseases Society of America (2008-08-01). "The management of encephalitis: clinical practice guidelines by the Infectious Diseases Society of America". Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America. 47 (3): 303–327. doi:10.1086/589747. ISSN 1537-6591. PMID 18582201.
  3. Tunkel, Allan R.; Glaser, Carol A.; Bloch, Karen C.; Sejvar, James J.; Marra, Christina M.; Roos, Karen L.; Hartman, Barry J.; Kaplan, Sheldon L.; Scheld, W. Michael; Whitley, Richard J.; Infectious Diseases Society of America (2008-08-01). "The management of encephalitis: clinical practice guidelines by the Infectious Diseases Society of America". Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America. 47 (3): 303–327. doi:10.1086/589747. ISSN 1537-6591. PMID 18582201.
  4. Tunkel, Allan R.; Glaser, Carol A.; Bloch, Karen C.; Sejvar, James J.; Marra, Christina M.; Roos, Karen L.; Hartman, Barry J.; Kaplan, Sheldon L.; Scheld, W. Michael; Whitley, Richard J.; Infectious Diseases Society of America (2008-08-01). "The management of encephalitis: clinical practice guidelines by the Infectious Diseases Society of America". Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America. 47 (3): 303–327. doi:10.1086/589747. ISSN 1537-6591. PMID 18582201.